Eagle Pharmaceuticals (EGRX)
(Delayed Data from NSDQ)
$4.60 USD
-0.18 (-3.77%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $4.61 +0.01 (0.22%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For EGRX
-
Eagle Pharmaceuticals (EGRX) Tops Q2 Earnings and Revenue Estimates
-
Eagle Pharmaceuticals: Q2 Earnings Snapshot
-
Eagle Pharmaceuticals Reports Second Quarter 2023 Results
-
Eagle Pharmaceuticals (EGRX) Q1 Earnings and Revenues Beat Estimates
-
Eagle Pharmaceuticals: Q1 Earnings Snapshot
-
Eagle Pharmaceuticals Reports First Quarter 2023 Results
-
Eagle Pharmaceuticals: Q4 Earnings Snapshot
-
Eagle Pharmaceuticals (EGRX) Beats Q4 Earnings and Revenue Estimates
-
Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results
-
Correcting & Replacing: Eagle Pharmaceuticals Reports Third Quarter 2022 Results
-
Eagle Pharmaceuticals (EGRX) Q3 Earnings and Revenues Beat Estimates
-
Eagle Pharmaceuticals: Q3 Earnings Snapshot
-
Eagle Pharmaceuticals Reports Third Quarter 2022 Results
-
Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Lag Estimates
-
Eagle Pharmaceuticals: Q2 Earnings Snapshot
-
Eagle Pharmaceuticals Reports Second Quarter 2022 Results
-
Eagle Pharmaceuticals (EGRX) Q1 Earnings Top Estimates
-
Eagle Pharmaceuticals (EGRX) Lags Q4 Earnings and Revenue Estimates
-
Eagle Pharmaceuticals (EGRX) Q3 Earnings and Revenues Lag Estimates
-
Analysts Estimate Eagle Pharmaceuticals (EGRX) to Report a Decline in Earnings: What to Look Out for
-
Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Surpass Estimates
-
Eagle Pharmaceuticals (EGRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Eagle Pharmaceuticals (EGRX) Q1 Earnings and Revenues Miss Estimates
-
Analysts Estimate Eagle Pharmaceuticals (EGRX) to Report a Decline in Earnings: What to Look Out for
-
Eagle Pharmaceuticals (EGRX) Beats Q4 Earnings Estimates